EVIDENCE LIBRARY
Remimazolam EEG Study Found Age-Related Signals Without Measuring Drug Concentrations
A prospective observational study found age-associated differences in EEG during remimazolam anesthesia. It did not determine whether those differences reflected exposure, sensitivity, coexisting disease, or a combination.
A prospective observational study found age-associated differences in EEG during remimazolam anesthesia. It did not determine whether those differences reflected exposure, sensitivity, coexisting disease, or a combination.
The signals observed
Bae and colleagues analyzed EEG recordings from 69 adults receiving remimazolam-based total intravenous anesthesia. Absolute alpha and beta power decreased with age, while the relative contribution of slower frequencies increased. Frontal coherence also declined with age in several bands.
The anesthetic was titrated to a patient-state-index target rather than delivered at a fixed rate. All patients also received remifentanil.
A monitoring target does not equal a measured concentration
Plasma remimazolam was not measured. Age-related dosing patterns and pharmacokinetic variation could therefore contribute to the EEG differences. Older participants also had more hypertension and diabetes.
The investigators did not assess how the signals translated into awareness, depth of anesthesia, or postoperative cognition. The study cannot validate an age-specific threshold for those functional outcomes merely from the correlations.
Practical interpretation
Retain age, co-administered drugs, titration method, and the actual EEG metric when using this evidence. An identical processed-monitor value need not imply identical underlying activity. Conversely, an age-related spectral difference cannot alone establish inadequate anesthesia or a medication-caused cognitive injury.
Source paper
Original analysis of the supplied journal article, identified as PMC13247345.